Literature DB >> 29550368

Asthma and COPD overlap pathophysiology of ACO.

Mari Hikichi1, Shu Hashimoto2, Yasuhiro Gon1.   

Abstract

Asthma and COPD appear as a result of different mechanisms triggered by different pathogeneses and although they present different features and symptoms of airway inflammation and airway obstruction, there are also cases that present the features of both asthma and COPD. This type of pathology is known as asthma-COPD overlap syndrome (ACOS). Asthma-COPD overlap is identified in clinical practice by the features that it shares with both asthma and COPD. This is not a definition, but a description for clinical use, as asthma-COPD overlap includes several different clinical phenotypes and there are likely to be several different underlying mechanisms". In this paper, the disease that shares several features of both asthma and COPD will be referred to as asthma-COPD overlap (ACO). In this article, we describe the pathogenesis of ACO for understanding the mechanism in asthma and COPD overlap.
Copyright © 2018 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACO; Asthma; British hypothesis; COPD; Dutch hypothesis

Mesh:

Year:  2018        PMID: 29550368     DOI: 10.1016/j.alit.2018.01.001

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  8 in total

Review 1.  Unraveling the Pathogenesis of Asthma and Chronic Obstructive Pulmonary Disease Overlap: Focusing on Epigenetic Mechanisms.

Authors:  Yung-Che Chen; Yu-Ping Chang; Kuo-Tung Huang; Po-Yuan Hsu; Chang-Chun Hsiao; Meng-Chih Lin
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

Review 2.  Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions.

Authors:  Evangelia Fouka; Andriana I Papaioannou; Georgios Hillas; Paschalis Steiropoulos
Journal:  J Pers Med       Date:  2022-04-28

3.  Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States.

Authors:  Monica D'Arcy; Donna R Rivera; Andrew Grothen; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

Review 4.  Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases.

Authors:  Anne M van der Does; Gimano D Amatngalim; Bart Keijser; Pieter S Hiemstra; Remi Villenave
Journal:  Vaccines (Basel)       Date:  2018-07-28

5.  Anti-angiogenic Properties of Bevacizumab Improve Respiratory System Inflammation in Ovalbumin-Induced Rat Model of Asthma.

Authors:  Seyed Mohammadreza Bolandi; Zohreh Abdolmaleki; Mohammad-Ali Assarehzadegan
Journal:  Inflammation       Date:  2021-08-21       Impact factor: 4.092

6.  Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males.

Authors:  Yong Jun Choi; Do Sun Kwon; Taehee Kim; Jae Hwa Cho; Hyung Jung Kim; Min Kwang Byun; Hye Jung Park
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

Review 7.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06

8.  The Association Between β-Dystroglycan in Airway Smooth Muscle and Eosinophils in Allergic Asthma.

Authors:  Suhayla H Shareef; Kawa Amin; Christer Janson
Journal:  Inflammation       Date:  2021-02-10       Impact factor: 4.657

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.